Small molecule inhibitors of snake venom metalloproteinases (SVMPs) could provide a means to rapidly halt the progression of local tissue damage following viperid snake envenomations. In this study, we examine the ability of candidate compounds based on a pentacyclic triterpene skeleton to inhibit SVMPs. We leverage molecular dynamics simulations to estimate the free energies of the candidate compounds for binding to BaP1, a P-I type SVMP, and compare these results with experimental assays of proteolytic activity inhibition in a homologous enzyme (Batx-I). Both simulation and experiment suggest that betulinic acid is the most active candidate, with the simulations predicting a standard binding free energy of Δ G ∘ = − 11.0...
Phospholipases A(2) (PLA(2)) are enzymes commonly found in snake venoms from Viperidae and Elaphidae...
Animal-derived antivenoms are the only specific therapies currently available for the treatment of s...
Due to the toxic pathophysiological role of snake venom phospholipase A2 (PLA2), its compelling limi...
Snakebites represent an important public health problem, with a great number of victims with permane...
The majority of snakebite envenomations in Central America are caused by the viperid species Bothrop...
The majority of snakebite envenomations in Central America are caused by the viperid species <i>Both...
BaP1, a zinc-dependent endopeptidase belonging to the P-I class of snake venom metalloproteinases, e...
Atrolysin C is a P-I snake venom metalloproteinase (SVMP) from Crotalus atrox venom, which efficient...
Most of the snakebite envenomations in Central and South America are caused by species belonging to ...
Snake venom metalloproteinases (SVMPs) participate in a number of important biological, physiologica...
Millions of people suffer from snake bite envenomation, and its management is a challenge, even toda...
Snakebite envenomings are a global public health issue. The therapy based on the administration of a...
The classical antivenom therapy has appreciably reduced snakebite mortality rate and thus is the onl...
The classical antivenom therapy has appreciably reduced snakebite mortality rate and thus is the onl...
The classical antivenom therapy has appreciably reduced snakebite mortality rate and thus is the onl...
Phospholipases A(2) (PLA(2)) are enzymes commonly found in snake venoms from Viperidae and Elaphidae...
Animal-derived antivenoms are the only specific therapies currently available for the treatment of s...
Due to the toxic pathophysiological role of snake venom phospholipase A2 (PLA2), its compelling limi...
Snakebites represent an important public health problem, with a great number of victims with permane...
The majority of snakebite envenomations in Central America are caused by the viperid species Bothrop...
The majority of snakebite envenomations in Central America are caused by the viperid species <i>Both...
BaP1, a zinc-dependent endopeptidase belonging to the P-I class of snake venom metalloproteinases, e...
Atrolysin C is a P-I snake venom metalloproteinase (SVMP) from Crotalus atrox venom, which efficient...
Most of the snakebite envenomations in Central and South America are caused by species belonging to ...
Snake venom metalloproteinases (SVMPs) participate in a number of important biological, physiologica...
Millions of people suffer from snake bite envenomation, and its management is a challenge, even toda...
Snakebite envenomings are a global public health issue. The therapy based on the administration of a...
The classical antivenom therapy has appreciably reduced snakebite mortality rate and thus is the onl...
The classical antivenom therapy has appreciably reduced snakebite mortality rate and thus is the onl...
The classical antivenom therapy has appreciably reduced snakebite mortality rate and thus is the onl...
Phospholipases A(2) (PLA(2)) are enzymes commonly found in snake venoms from Viperidae and Elaphidae...
Animal-derived antivenoms are the only specific therapies currently available for the treatment of s...
Due to the toxic pathophysiological role of snake venom phospholipase A2 (PLA2), its compelling limi...